Connect Biopharma Holdings (CNTB) Exchange Rate Effect (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted Exchange Rate Effect of $72000.0 for Q1 2026, up 41.18% sequentially from $51000.0 in Q4 2025, and down 4.0% YoY from $75000.0 in Q1 2025.
Connect Biopharma Holdings (CNTB) Exchange Rate Effect (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings has reported Exchange Rate Effect for 3 years, with the latest figure at $72000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 4.0% year-over-year to $72000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $405000.0 (up 235.45% YoY) and the FY2025 annual result came in at $408000.0, up 168.57% from the prior year.
- Exchange Rate Effect grew to $72000.0 in Q1 2026 per CNTB's latest filing, from $51000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $507000.0 in Q3 2024 and troughed at -$983000.0 in Q4 2024.
- A 3-year average of -$12777.8 and a median of $72000.0 in 2026 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 133.94% in 2025, down 88.56% in 2025.
- Over 3 years, Exchange Rate Effect stood at -$983000.0 in 2024, then surged by 105.19% to $51000.0 in 2025, then soared by 41.18% to $72000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $72000.0, $51000.0, and $58000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Connect Biopharma Holdings | 148.41 Mn | 148.41 Mn | - | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45,000.00 |
| Jun 30, 2026 | 45,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Mar 31, 2026 | 72,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Jun 30, 2025 | 224,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Jun 30, 2024 | 102,000.00 |
| Mar 31, 2024 | -221,000.00 |
| Mar 31, 2024 | -221,000.00 |